SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040604
Filing Date
2023-08-09
Accepted
2023-08-09 16:15:02
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-20230630.htm   iXBRL 10-Q 2328524
2 EX-10.1 allk-ex10_1.htm EX-10.1 42370
3 EX-31.1 allk-ex31_1.htm EX-31.1 21802
4 EX-31.2 allk-ex31_2.htm EX-31.2 21825
5 EX-32.1 allk-ex32_1.htm EX-32.1 12075
6 EX-32.2 allk-ex32_2.htm EX-32.2 12094
  Complete submission text file 0000950170-23-040604.txt   9208582

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20230630_pre.xml EX-101.PRE 310200
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20230630.xsd EX-101.SCH 47858
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allk-20230630_def.xml EX-101.DEF 163724
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allk-20230630_cal.xml EX-101.CAL 44017
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20230630_lab.xml EX-101.LAB 430023
60 EXTRACTED XBRL INSTANCE DOCUMENT allk-20230630_htm.xml XML 2021465
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 231155338
SIC: 2834 Pharmaceutical Preparations